Sfoglia per AUTORE
CIABATTI E
Collezione AOU Alessandria

  

Items : 7

Local radiotherapy and measurable residual disease-driven immunotherapy in patients with early-stage follicular lymphoma (FIL MIRO): final results of a prospective, multicentre, phase 2 trial. in The Lancet. Haematology / Lancet Haematol. 2024 Jul;11(7):e499-e509. doi: 10.1016/S2352-3026(24)00143-1.

2024
AOU Alessandria
AOU Città della Salute di Torino

Della Starza I; Drandi D; Genuardi E; Ciabatti E; Bomben R; De Novi LA; Cavalli M; Guarini A; Grapulin L; Assanto GM; Annechini G; Tani M; Celli M; Mannina D; Mannarella C; Cencini E; Re F; Bigliardi S; Corradini P; Stelitano C; Tucci A; Perrone T; Gaidano G; Musuraca G; Bernuzzi P; Bolis SA; Zilioli VR; Rattotti S; Ferreri AJM; et alii...

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network. in HemaSphere / Hemasphere. 2021 Sep 6;5(10):e639. doi: 10.1097/HS9.0000000000000639. eCollection 2021 Oct.

2021
AOU Alessandria
AOU Città della Salute di Torino

Gaidano G; Del Giudice I; Galimberti S; Gattei V; Agostinelli C; García-Sanz R; Delfau-Larue MH; Pott C; Alessandria B; Degan M; Bomben R; Gazzola A; Mannu C; Cavalli M; De Novi LA; Ciabatti E; Grassi S; Della Starza I; Ferrante M; Genuardi E; Mantoan B; Ladetto M; Ferrero S; Drandi D;

Eight-year follow up of a case of persistent polyclonal B cell lymphocytosis: Immunophenotypic findings pre- and postsplenectomy. in Cytometry. Part B, Clinical cytometry / Cytometry B Clin Cytom. 2021 Nov;100(6):687-688. doi: 10.1002/cyto.b.21976. Epub 2020 Dec 3.

2021
AOU Alessandria

Ciancia E; Ciabatti E; Sammuri P; Manzato E; Tavarozzi R; Carulli G;

Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma. in Hematological oncology / Hematol Oncol. 2020 Dec;38(5):698-704. doi: 10.1002/hon.2792. Epub 2020 Aug 28.

2020
AOU Alessandria
AOU Città della Salute di Torino

Ladetto M; Ferrero S; Foà R; Guarini A; Cortelazzo S; Martelli M; Galimberti S; Di Rocco A; Gattei V; Degan M; Grassi S; Bomben R; Ciabatti E; Monitillo L; Barbero D; Ferrante M; Drandi D; Mantoan B; Genuardi E; Soscia R; Novelli N; Cavalli M; De Novi LA; Della Starza I; Del Giudice I;

Droplet Digital PCR Quantification of Mantle Cell Lymphoma Follow-up Samples From Four Prospective Trials of the European MCL Network. in HemaSphere / Hemasphere. 2020 Apr 3;4(2):e347. doi: 10.1097/HS9.0000000000000347. eCollection 2020 Apr.

2020
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Dreyling M; Cortelazzo S; Ribrag V; Eckert C; Abdo C; Callanan M; Jimenez C; Ciabatti E; Bomben R; Starza ID; Cheminant M; Villarese P; Mantoan B; Genuardi E; Ferrante M; Zaccaria G; Lhermitte L; Söhlbrandt A; Benmaad I; Alcantara M; Drandi D; Delfau-Larue MH; Pott C; Ladetto M; Ferrero S; Macintyre E;

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network. in Hematological oncology / Hematol Oncol. 2019 Oct;37(4):368-374. doi: 10.1002/hon.2652. Epub 2019 Aug 16.

2019
AOU Alessandria

Della Starza I; Cavalli M; De Novi LA; Genuardi E; Mantoan B; Drandi D; Barbero D; Ciabatti E; Grassi S; Gazzola A; Mannu C; Agostinelli C; Piccaluga PP; Bomben R; Degan M; Gattei V; Guarini A; Foà R; Galimberti S; Ladetto M; Ferrero S; Del Giudice I;

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. in International journal of laboratory hematology / Int J Lab Hematol. 2018 Apr;40(2):201-208. doi: 10.1111/ijlh.12766. Epub 2017 Dec 4.

2018
AOU Alessandria

Genuardi E; Barbero D; Dogliotti I; Mantoan B; Drandi D; Gambella M; Zaccaria GM; Monitillo L; Della Starza I; Cavalli M; De Novi LA; Ciabatti E; Grassi S; Gazzola A; Mannu C; Del Giudice I; Galimberti S; Agostinelli C; Piccaluga PP; Ladetto M; Ferrero S;